Due to COVID-19, new enrollment in research studies will be greatly limited.
If you are interested in a study, there may be a longer waiting period to receive a response to your inquiry.
View the guidance for research participants for additional information.
This study enrolls children and young adults with Juvenile idiopathic arthritis. The purpose of this study is to understand the relationship between biochemical and genetic markers and the way a person's body responds to drugs. We also want to learn more about the development of lung disease in people with systemic juvenile idiopathic arthritis. Read More
-Children and young adults ages 1-21.
-Diagnosed with Juvenile idiopathic arthritis (sJIA) and has lung involvement.
This study enrolls medical students. The goal of the study is to learn if measurements we take through brain imaging, video, and eye tracking can show the difference between experts and novices when they do emergency medical tasks. Read More
-Adults ages 18+.
-Are a medical student practicing physician with experience in emergency medicine or prolonged field care skills OR do not have experience with emergency medicine or prolonged field care tasks.
-Are able to stand continuously for 20 minutes.
This study enrolls adults with a common type of heart failure (called “preserved ejection fraction” or HFpEF) that has no proven treatment and is often the result of poorly controlled high blood pressure. The purpose of this study is to learn if the new investigational drug finerenone improves outcomes and is safe in patients with HFpEF. Read More
-Adults ages 40+.
-Diagnosed with heart failure (class II-IV).
This study enrolls children who are having orthodontic treatment and need a rapid maxillary expansion (RME) device. The purpose of this study is to learn about the effects of palatal expansion on jaw movement during sleep. Read More
-Children ages 7-14.
-Are under orthodontic care and need to use a rapid maxillary expansion (RME) device
Are you the parent of a child who was diagnosed with Tourette Syndrome, or Cerebral Palsy or the parent of a child (children) with no known disability? We are hoping to learn more about the burdens caregivers face caring for children with disabilities and how that is different from the burdens of parents with children without a disability. Read More
Adult parents/caregivers ages 18+.
Your child is ages 5-12.
Your child has been diagnosed with Cerebral Palsy or with Tourette Syndrome *OR* your child (children) have no known disabilities.
The child must live with the primary and/or secondary caregiver.
This study enrolls adults who have a household member diagnosed with COVID-19 in the past 96 hours but who do not have symptoms themselves. The purpose of this study is to find out if an investigational drug is safe and effective at preventing or reducing symptoms and COVID infection Read More
Adults ages 18+.
Do not have symptoms of COVID-19
Have a household member who has been diagnosed with COVID-19 in the past 96 hours.
This study enrolls adults who have had a positive test for COVID-19. The purpose of this study is to learn more about how the infection works, including how the virus evolves and how a person infected with COVID-19's body responds. Knowing more about the virus at a cellular level will help scientists develop better treatments for this devastating disease. Read More
-Positive for COVID-19
-We will restrict asymptomatic enrollees to a maximum of 20% (100) participants. Once that number is achieved, symptoms of COVID-19 will be required for inclusion in to the study.
This study enrolls people who are currently hospitalized due to COVID-19. The purpose of this study is to learn about the safety and effectiveness of an investigational drug called APL-9. We want to know if this investigational drug helps patients recover from COVID-19 related lung inflammation faster. Read More
Adults ages 18+.
Confirmed COVID-19 infection.
Diagnosis of mild to moderate acute respiratory distress syndrome (ARDS) and need mechanical ventilation.
Have not been treated with convalescent plasma for COVID-19.
No evidence of kidney or liver failure.